SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-21-000027
Filing Date
2021-04-28
Accepted
2021-04-28 16:50:10
Documents
88
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20210331.htm   iXBRL 10-Q 1911324
2 EX-31.1 opk-3312021xex311.htm EX-31.1 9429
3 EX-31.2 opk-3312021xex312.htm EX-31.2 9406
4 EX-32.1 opk-3312021xex321.htm EX-32.1 3698
5 EX-32.2 opk-3312021xex322.htm EX-32.2 3731
  Complete submission text file 0000944809-21-000027.txt   10279369

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20210331.xsd EX-101.SCH 68062
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20210331_cal.xml EX-101.CAL 111450
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20210331_def.xml EX-101.DEF 429582
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20210331_lab.xml EX-101.LAB 873771
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20210331_pre.xml EX-101.PRE 597506
11 EXTRACTED XBRL INSTANCE DOCUMENT opk-20210331_htm.xml XML 1840911
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 21865036
SIC: 2834 Pharmaceutical Preparations